Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanur Healthcare is a South African pharmaceutical company dedicated to providing innovative and accessible healthcare solutions. The company offers a diverse portfolio of over-the-counter (OTC) and prescription medications targeting therapeutic areas such as respiratory health, gastrointestinal disorders, women's health, and dermatology. Key brands include Q-TUSS cough syrup, Sinucon nasal drops, and Enteron probiotics, which are widely distributed across South Africa. Formerly known as Dezzo Trading 392, the company was acquired by Austell Pharmaceuticals in 2020 and continues to operate as a key player in the South African pharmaceutical market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanur Healthcare.